From March 21 to 23, 2026, the 23rd China International Conference & Exhibition on Laboratory Medicine and Blood Transfusion (CACLP) concluded successfully at the Xiamen International Expo Center after a dynamic three-day run. As a leading provider of core raw materials for in vitro diagnostics (IVD), Cnpair made a remarkable appearance, showcasing our innovative capabilities at Booth 4-0514 in Hall 4. Featured exhibits included raw materials for sexually transimitted diseases(STDs) and high-activity native materials, comprehensively demonstrating Cnpair’s integrated “product × service” solutions from raw materials to applications—earning trust through strength and achieving win-win cooperation through partnership.
A Standout Presence at CACLP 2026
Throughout the exhibition, the Cnpair booth attracted a steady stream of visitors. Customers, partners, and industry experts from around the world gathered for in-depth discussions, with every interaction reflecting the trust and support of our global community. Cnpair remains committed to advancing technological innovation and process optimization in raw materials, continuously delivering high-quality core components to the IVD industry.
Driving Global Conversations: Insights from Dr. Haifeng Luo
During the event, Dr. Haifeng Luo, co-founder of Cnpair, was invited to attend Enlightening Lab Med -The 9th lVD Youth Entrepreneur Forum and Co clobal: china lVD International Forum 2026, where he shared in-depth insights on industry development and global strategy. Dr. Luo emphasized that Cnpair has established a full-chain “products + services” matrix, positioning the company not only as a supplier of raw materials, but also as a strategic partner working alongside its customers.
In response to both opportunities and challenges in the evolving industry landscape, Cnpair will continue to strengthen its development resilience, maintain operational agility, and uphold a win-win cooperation philosophy to navigate uncertainties together with its partners. The company has formulated a clear, phased global expansion roadmap and will steadily advance its international strategy—progressing from a traditional “supply chain” to a collaborative “value chain” that drives mutual success.
Looking Ahead: Innovation and Partnership
With this, Cnpair’s journey at CACLP 2026 in Xiamen comes to a successful close. We showcased our product strengths and technological innovations, engaged deeply with industry peers, and are sincerely grateful for the trust and support of both new and long-standing customers.
Looking ahead, Cnpair will stay true to its mission and continue to innovate. We are confident in the future of the IVD industry and even more confident in our own growth potential. We look forward to working hand in hand with industry partners to promote high-quality development in in vitro diagnostics.See you at CACLP next year!
